Processa Pharmaceuticals Inc (PCSA)
2.09
-0.04
(-1.88%)
USD |
NASDAQ |
May 10, 16:00
2.09
0.00 (0.00%)
After-Hours: 20:00
Processa Pharmaceuticals Cash from Operations (TTM): -8.063M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -8.063M |
September 30, 2023 | -8.437M |
June 30, 2023 | -9.650M |
March 31, 2023 | -9.916M |
December 31, 2022 | -9.605M |
September 30, 2022 | -9.835M |
June 30, 2022 | -8.413M |
March 31, 2022 | -8.277M |
December 31, 2021 | -8.717M |
September 30, 2021 | -8.266M |
June 30, 2021 | -6.684M |
March 31, 2021 | -4.840M |
December 31, 2020 | -3.143M |
September 30, 2020 | -1.481M |
June 30, 2020 | -2.232M |
March 31, 2020 | -2.689M |
December 31, 2019 | -2.750M |
September 30, 2019 | -2.601M |
June 30, 2019 | -2.890M |
March 31, 2019 | -3.246M |
December 31, 2018 | -3.708M |
September 30, 2018 | -4.649M |
June 30, 2018 | -3.812M |
Date | Value |
---|---|
March 31, 2018 | -2.722M |
December 31, 2017 | -1.655M |
September 30, 2017 | -0.257M |
June 30, 2017 | -0.0665M |
March 31, 2017 | 0.0056M |
December 31, 2016 | -0.0432M |
September 30, 2016 | -0.0823M |
June 30, 2016 | -0.1462M |
March 31, 2016 | -0.4202M |
December 31, 2015 | -0.8719M |
September 30, 2015 | -1.281M |
June 30, 2015 | -1.774M |
March 31, 2015 | -2.206M |
December 31, 2014 | -2.692M |
September 30, 2014 | -2.699M |
June 30, 2014 | -2.868M |
March 31, 2014 | -2.934M |
December 31, 2013 | -2.539M |
September 30, 2013 | -2.724M |
June 30, 2013 | -2.671M |
March 31, 2013 | -2.289M |
December 31, 2012 | -1.892M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-9.916M
Minimum
Mar 2023
-1.481M
Maximum
Sep 2020
-6.236M
Average
-8.063M
Median
Dec 2023
Cash from Operations (TTM) Benchmarks
DIH Holding US Inc | -- |
NovaBay Pharmaceuticals Inc | -4.131M |
Palatin Technologies Inc | -26.54M |
iBio Inc | -18.89M |
Theriva Biologics Inc | -19.00M |